journal article·2019-06-10

Heparin/Collagen Coatings Improve Human Mesenchymal Stromal Cell Response to Interferon Gamma

David A. Castilla-Casadiego, José R. García, Andrés J. García, Jorge Almodovar

Publisher page

Abstract

Mesenchymal stromal cells (MSC) are a promising source for cell-based therapies as they secrete a myriad of reparative factors in response to inflammatory stimuli. In this study, multilayers of heparin and collagen (HEP/COL) were used as a bioactive surface coating to enhance human MSC (hMSC) response to soluble interferon-gamma (IFN-γ). Multilayers were formed, via layer-by-layer assembly, varying the final layer between COL and HEP and supplemented with IFN-γ in the culture medium. hMSC adhesion, proliferation, and cytokine expression were assessed. Infrared variable angle spectroscopic ellipsometry confirmed film chemistry, thickness, and roughness. COL-ending films of 12 layers of HEP/COL had an average thickness of 129 ± 5.8 nm, and 13 layers (HEP-ending) were 178 ± 28.3 nm thick. Changes in temperature between 25-37 °C did not have significant effects on film chemistry, thickness, or roughness. An EdU incorporation assay revealed that IFN-γ had an antiproliferative effect in all conditions evaluated except when hMSCs were cultured on HEP-ending films supplemented with IFN-γ. Moreover, hMSCs cultured on HEP-ending films supplemented with IFN-γ had a higher cytokine expression as compared with cells cultured on tissue culture polystyrene, COL-ending films with and without IFN-γ, and HEP-ending films without IFN-γ as measured by Luminex assay. Finally, immunostaining revealed strong integrin binding and FAK phosphorylation for each condition. This study shows that HEP/COL films can modulate hMSC response to soluble factors, which may be exploited in cell manufacturing practices.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Proteoglycans and glycosaminoglycans research · Cell Adhesion Molecules Research · Osteoarthritis Treatment and Mechanisms

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemical Engineering, University of Puerto Rico Mayaguez, Call Box 9000, Mayaguez, Puerto Rico 00681-9000, United States

Woodruff School of Mechanical Engineering, Petit Institute for Bioengineering and Bioscience, 315 Ferst Dr., Georgia Institute of Technology, Atlanta, Georgia 30332-0363, United States

Funding

Army Research Office · Division of Engineering Education and Centers

References (95)

Show source-provided references
1. 10.1038/srep1633610.1038/srep16336 ↗
2. 10.1002/jbm.a.3284710.1002/jbm.a.32847 ↗
3. 10.1002/adma.20060011310.1002/adma.200600113 ↗
4. 10.1021/cm203245910.1021/cm2032459 ↗
5. Crespilho F. N. · Int. J. Electrochem. · 2006 · 1 · 19410.1016/S1452-3981(23)17150-1 ↗
6. 10.1016/j.colsurfa.2018.05.05210.1016/j.colsurfa.2018.05.052 ↗
7. 10.1021/bm200519y10.1021/bm200519y ↗
8. 10.1021/bm800257310.1021/bm8002573 ↗
9. 10.1021/bm801237810.1021/bm8012378 ↗
10. 10.1002/adfm.20070129710.1002/adfm.200701297 ↗
11. 10.2174/09298670878388521910.2174/092986708783885219 ↗
12. 10.1088/1748-3182/8/4/04500510.1088/1748-3182/8/4/045005 ↗
13. 10.1021/ie500122u10.1021/ie500122u ↗
14. 10.1002/adma.20180109710.1002/adma.201801097 ↗
15. 10.1116/1.494304610.1116/1.4943046 ↗
16. 10.1002/adfm.20040010610.1002/adfm.200400106 ↗
17. 10.1016/j.jconrel.2006.03.01610.1016/j.jconrel.2006.03.016 ↗
18. 10.1083/jcb.20110214710.1083/jcb.201102147 ↗
19. 10.1089/ten.2004.10.114810.1089/ten.2004.10.1148 ↗
20. 10.1002/bit.1037210.1002/bit.10372 ↗
21. 10.1016/j.actbio.2017.11.02010.1016/j.actbio.2017.11.020 ↗
22. 10.3390/ma303186310.3390/ma3031863 ↗
23. 10.1074/jbc.M11070920010.1074/jbc.M110709200 ↗
24. 10.1007/978-3-319-70049-6_210.1007/978-3-319-70049-6_2 ↗
25. 10.1016/0142-9612(93)90039-510.1016/0142-9612(93)90039-5 ↗
26. 10.1016/j.actbio.2018.04.04710.1016/j.actbio.2018.04.047 ↗
27. 10.1016/j.tsf.2013.09.09310.1016/j.tsf.2013.09.093 ↗
28. 10.1002/bip.2087110.1002/bip.20871 ↗
29. 10.1074/jbc.M50772920010.1074/jbc.M507729200 ↗
30. 10.1074/jbc.273.39.2497910.1074/jbc.273.39.24979 ↗
31. 10.1146/annurev.biochem.68.1.72910.1146/annurev.biochem.68.1.729 ↗
32. 10.1016/j.apsusc.2009.03.01110.1016/j.apsusc.2009.03.011 ↗
33. 10.1016/j.apsusc.2015.11.22710.1016/j.apsusc.2015.11.227 ↗
34. 10.1007/s00417-015-3144-610.1007/s00417-015-3144-6 ↗
35. 10.1016/j.biomaterials.2010.01.09210.1016/j.biomaterials.2010.01.092 ↗
36. 10.1021/am401706w10.1021/am401706w ↗
37. 10.1016/S0171-2985(89)80049-X10.1016/S0171-2985(89)80049-X ↗
38. 10.1371/journal.pone.012969410.1371/journal.pone.0129694 ↗
39. 10.1002/hep.2678210.1002/hep.26782 ↗
40. 10.1128/JVI.01571-0610.1128/JVI.01571-06 ↗
41. 10.1016/S0065-2776(07)96002-210.1016/S0065-2776(07)96002-2 ↗
42. 10.1200/JCO.1991.9.10.183110.1200/JCO.1991.9.10.1831 ↗
43. 10.1007/BF0199050110.1007/BF01990501 ↗
44. 10.1074/jbc.273.18.1091910.1074/jbc.273.18.10919 ↗
45. 10.1172/JCI11509310.1172/JCI115093 ↗
46. 10.1002/eji.20073812910.1002/eji.200738129 ↗
47. 10.1111/j.1365-2249.2007.03422.x10.1111/j.1365-2249.2007.03422.x ↗
48. 10.1007/s12015-014-9495-210.1007/s12015-014-9495-2 ↗
49. 10.1073/pnas.161793311410.1073/pnas.1617933114 ↗
50. 10.1016/j.joen.2015.02.01810.1016/j.joen.2015.02.018 ↗
51. 10.1371/journal.pone.001469810.1371/journal.pone.0014698 ↗
52. Cabral J. M. S. · 2016
53. 10.3727/096368915X68684110.3727/096368915X686841 ↗
54. 10.1038/bmt.2016.2010.1038/bmt.2016.20 ↗
55. 10.4103/1673-5374.15695310.4103/1673-5374.156953 ↗
56. 10.5966/sctm.2016-007110.5966/sctm.2016-0071 ↗
57. 10.3978/j.issn.2224-4336.2014.03.0510.3978/j.issn.2224-4336.2014.03.05 ↗
58. 10.2337/db12-035510.2337/db12-0355 ↗
59. 10.1016/j.pmrj.2009.02.01310.1016/j.pmrj.2009.02.013 ↗
60. 10.1016/j.addr.2011.06.01010.1016/j.addr.2011.06.010 ↗
61. 10.3978/j.issn.2306-9759.2014.08.0210.3978/j.issn.2306-9759.2014.08.02 ↗
62. 10.1089/scd.2015.000810.1089/scd.2015.0008 ↗
63. 10.2174/18715280978846263510.2174/187152809788462635 ↗
64. 10.1557/PROC-121-71710.1557/PROC-121-717 ↗
65. 10.1016/j.biomaterials.2018.03.02710.1016/j.biomaterials.2018.03.027 ↗
66. 10.2174/09298670778059790710.2174/092986707780597907 ↗
67. Borsellino N. · Anticancer. Drugs · 1993 · 4 · 26510.1097/00001813-199304000-00020 ↗
68. Gajewski T. F. · J. Immunol. · 1988 · 141 · 263510.4049/jimmunol.141.8.2635 ↗
69. 10.1006/gyno.2002.670710.1006/gyno.2002.6707 ↗
70. 10.1016/S0344-0338(11)80996-910.1016/S0344-0338(11)80996-9 ↗
71. 10.1016/0049-3848(94)90136-810.1016/0049-3848(94)90136-8 ↗
72. 10.1021/bi00430a04710.1021/bi00430a047 ↗
73. 10.1046/j.1365-2249.2000.01178.x10.1046/j.1365-2249.2000.01178.x ↗
74. 10.1021/bm100579910.1021/bm1005799 ↗
75. 10.1016/j.biomaterials.2014.01.01210.1016/j.biomaterials.2014.01.012 ↗
76. 10.1016/j.biomaterials.2014.02.00810.1016/j.biomaterials.2014.02.008 ↗
77. 10.1074/jbc.271.27.1613910.1074/jbc.271.27.16139 ↗
78. 10.1083/jcb.104.3.68910.1083/jcb.104.3.689 ↗
79. 10.1046/j.1365-2249.2000.01178.x10.1046/j.1365-2249.2000.01178.x ↗
80. 10.1007/978-3-0348-0620-6_179-110.1007/978-3-0348-0620-6_179-1 ↗
81. 10.1007/978-1-4419-9148-5_1310.1007/978-1-4419-9148-5_13 ↗
82. 10.1016/j.febslet.2009.07.05610.1016/j.febslet.2009.07.056 ↗
83. 10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V ↗
84. 10.1016/j.omtm.2017.06.00510.1016/j.omtm.2017.06.005 ↗
85. 10.1002/eji.183027114010.1002/eji.1830271140 ↗
86. Hotfilder M. · Anticancer Res. · 2000 · 20 · 4445
87. 10.1016/j.celrep.2018.02.01310.1016/j.celrep.2018.02.013 ↗
88. 10.1182/blood-2002-04-116410.1182/blood-2002-04-1164 ↗
89. 10.1073/pnas.080613610510.1073/pnas.0806136105 ↗
90. 10.1002/wdev.17610.1002/wdev.176 ↗
91. 10.1016/0955-0674(94)90091-410.1016/0955-0674(94)90091-4 ↗
92. 10.1016/S1357-2725(97)00051-410.1016/S1357-2725(97)00051-4 ↗
93. 10.1074/jbc.M61067220010.1074/jbc.M610672200 ↗
94. 10.1016/j.jcyt.2018.10.01410.1016/j.jcyt.2018.10.014 ↗
95. 10.3389/fmed.2018.0017810.3389/fmed.2018.00178 ↗